Laboratory Benchtop Automation Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview
The Laboratory Benchtop Automation Market is expected to grow from USD 1,325 million in 2024 to approximately USD 2,033.45 million by 2032, at a compound annual growth rate (CAGR) of 5.5% over the forecast period.
This growth is driven by the rising demand for high-throughput testing in diagnostic laboratories and research settings, alongside an increasing focus on personalized medicine and accelerated drug discovery. Integration of artificial intelligence (AI) and machine learning (ML) into benchtop automation enhances data accuracy, streamlines complex processes, and improves overall laboratory efficiency.
Advancements in miniaturization and modular system designs are making automation more accessible to small and mid-sized labs, expanding the market’s reach. Additionally, stringent regulatory standards in pharmaceutical and clinical testing are reinforcing the need for consistent and precise automated workflows, positioning benchtop automation as an essential tool for compliance and quality assurance.
Market Drivers
1. Rise of Personalized Medicine and Drug Discovery
The increasing global focus on personalized treatment approaches and rapid drug development pipelines is fueling demand for benchtop automation systems. These technologies support high-throughput screening, large-scale data processing, and precise workflow management, which are critical in genomics, proteomics, and metabolomics research.
For example, systems like Illumina’s NextSeq 2000 enable sequencing at a scale that supports personalized healthcare by delivering up to 1,200 gigabases per run. Automation in such settings enables laboratories to reduce turnaround time, increase accuracy, and manage costs more effectively—making it an indispensable asset in modern biomedical research and pharmaceutical R&D.
Market Challenges
1. High Capital Investment and Maintenance Costs
One of the major barriers to widespread adoption of laboratory benchtop automation is the high upfront cost of equipment procurement, integration, and ongoing maintenance. Smaller laboratories often struggle with the financial burden of acquiring advanced systems, especially when combined with the need for technical training, software integration, and routine system upkeep.
In emerging markets or resource-limited settings, these costs can be particularly prohibitive, limiting access to automation technologies despite the clear operational benefits. The requirement for skilled technicians to operate and troubleshoot equipment further adds to the total cost of ownership, impacting adoption rates.
Market Segmentation
By Product Type
Automated Liquid Handling & Dispensing Systems
Sample Storage and Handling Equipment
Robotic Systems
System Accessories
By End Use
Research & Development Institutes
Pharmaceutical Companies
Hospitals & Diagnostic Centers
Other End Users
By Region
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Italy, Spain, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East & Africa: GCC Countries, South Africa, Rest of MEA
Key Market Players
Abbott
Agilent Technologies
Beckman Coulter Inc.
BioTek Instruments
Danaher Corporation
Eppendorf
Logos Biosystems Inc.
PerkinElmer
QIAGEN
Siemens Healthcare
Thermo Fisher Scientific
The Laboratory Benchtop Automation Market is expected to grow from USD 1,325 million in 2024 to approximately USD 2,033.45 million by 2032, at a compound annual growth rate (CAGR) of 5.5% over the forecast period.
This growth is driven by the rising demand for high-throughput testing in diagnostic laboratories and research settings, alongside an increasing focus on personalized medicine and accelerated drug discovery. Integration of artificial intelligence (AI) and machine learning (ML) into benchtop automation enhances data accuracy, streamlines complex processes, and improves overall laboratory efficiency.
Advancements in miniaturization and modular system designs are making automation more accessible to small and mid-sized labs, expanding the market’s reach. Additionally, stringent regulatory standards in pharmaceutical and clinical testing are reinforcing the need for consistent and precise automated workflows, positioning benchtop automation as an essential tool for compliance and quality assurance.
Market Drivers
1. Rise of Personalized Medicine and Drug Discovery
The increasing global focus on personalized treatment approaches and rapid drug development pipelines is fueling demand for benchtop automation systems. These technologies support high-throughput screening, large-scale data processing, and precise workflow management, which are critical in genomics, proteomics, and metabolomics research.
For example, systems like Illumina’s NextSeq 2000 enable sequencing at a scale that supports personalized healthcare by delivering up to 1,200 gigabases per run. Automation in such settings enables laboratories to reduce turnaround time, increase accuracy, and manage costs more effectively—making it an indispensable asset in modern biomedical research and pharmaceutical R&D.
Market Challenges
1. High Capital Investment and Maintenance Costs
One of the major barriers to widespread adoption of laboratory benchtop automation is the high upfront cost of equipment procurement, integration, and ongoing maintenance. Smaller laboratories often struggle with the financial burden of acquiring advanced systems, especially when combined with the need for technical training, software integration, and routine system upkeep.
In emerging markets or resource-limited settings, these costs can be particularly prohibitive, limiting access to automation technologies despite the clear operational benefits. The requirement for skilled technicians to operate and troubleshoot equipment further adds to the total cost of ownership, impacting adoption rates.
Market Segmentation
By Product Type
Automated Liquid Handling & Dispensing Systems
Sample Storage and Handling Equipment
Robotic Systems
System Accessories
By End Use
Research & Development Institutes
Pharmaceutical Companies
Hospitals & Diagnostic Centers
Other End Users
By Region
North America: U.S., Canada, Mexico
Europe: Germany, France, U.K., Italy, Spain, Rest of Europe
Asia Pacific: China, Japan, India, South Korea, Southeast Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Rest of Latin America
Middle East & Africa: GCC Countries, South Africa, Rest of MEA
Key Market Players
Abbott
Agilent Technologies
Beckman Coulter Inc.
BioTek Instruments
Danaher Corporation
Eppendorf
Logos Biosystems Inc.
PerkinElmer
QIAGEN
Siemens Healthcare
Thermo Fisher Scientific
Table of Contents
187 Pages
- 1. Executive Summary
- 1.1 Market Overview
- 1.2 Key Market Highlights
- 1.3 Strategic Insights
- 1.4 Market Forecast Summary
- 2. Introduction
- 2.1 Definition and Scope of the Market
- 2.2 Research Methodology
- 2.3 Assumptions and Limitations
- 3. Market Overview and Dynamics
- 3.1 Market Drivers
- 3.2 Market Restraints
- 3.3 Opportunities in Emerging Markets
- 3.4 Technology Trends and Advancements
- 3.5 Regulatory and Compliance Landscape
- 4. Market Segmentation
- 4.1 By Product Type:
- Automated Pipetting Systems
- Microplate Readers
- Liquid Handling Workstations
- Robotic Arms
- Automated Incubators
- Sample Preparation Systems
- Others
- 4.2 By End Use:
- Biotechnology and Pharmaceutical Companies
- Clinical and Diagnostic Laboratories
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
- 4.3 By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- 5. Competitive Landscape
- 5.1 Market Share Analysis
- 5.2 Competitive Benchmarking
- 5.3 Strategic Developments (Partnerships, M&A, New Product Launches)
- 6. Key Player Analysis
- Detailed company profiles, financials, product portfolio, and strategic initiatives:
- ABBOTT
- Agilent Technologies
- Beckman Coulter Inc.
- Biotek Instruments
- Danaher Corporation
- Eppendorf
- Logos Biosystems Inc.
- PerkinElmer
- QIAGEN
- Siemens Healthcare
- Thermo Fisher Scientific
- 7. Technology Landscape
- 7.1 Integration of AI and IoT in Lab Automation
- 7.2 Advances in Miniaturization and Precision
- 7.3 Cloud-based Data Management Solutions
- 8. Market Forecast and Opportunity Analysis
- 8.1 Global Market Size Projections (2024–2030)
- 8.2 Segmental Forecast by Product Type, End Use, and Region
- 8.3 Investment and Funding Trends
- 9. Conclusion and Strategic Outlook
- 9.1 Key Takeaways
- 9.2 Growth Opportunities
- 9.3 Recommendations for Stakeholders
- 10. Appendices
- 10.1 Glossary of Terms
- 10.2 Abbreviations
- 10.3 References
- 10.4 Methodology Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
